| Literature DB >> 33067060 |
Frances M Russell1, Alfred Wang2, Robert R Ehrman3, Jake Jacobs2, Alex Croft2, Caleb Larsen2.
Abstract
BACKGROUND: No set guidelines to guide disposition decisions from the emergency department (ED) in patients with COVID-19 exist. Our goal was to determine characteristics that identify patients at high risk for adverse outcomes who may need admission to the hospital instead of an observation unit.Entities:
Keywords: Adverse outcomes; COVID-19; Observation unit; Risk stratification
Year: 2020 PMID: 33067060 PMCID: PMC7543733 DOI: 10.1016/j.ajem.2020.10.009
Source DB: PubMed Journal: Am J Emerg Med ISSN: 0735-6757 Impact factor: 2.469
Fig. 1Patient flow through study.
Characteristics of patients requiring admission versus those discharged, n = 116
| Admitted ( | Discharged ( | P-Value | |
|---|---|---|---|
| Age (years), Median (Range) | 52.4 (21–85) | 52.6 (20–81) | 0.9400 |
| Gender (%) | 0.4138 | ||
| Female | 14 (42.4) | 43 (51.8) | |
| Male | 19 (57.6) | 40 (48.1) | |
| Race | 0.014 | ||
| Black | 10 (30.3) | 36 (43.4) | |
| Hispanic | 18 (54.5) | 20 (24.1) | |
| White | 3 (9.0) | 20 (24.1) | |
| Other | 2 (6.1) | 7 (8.4) | |
| Metric BMI, Median (Q1, Q3) | 29.1 (25.6, 32.7) | 28.9 (25.0, 35.9) | 0.9500 |
| Symptom onset, days (range) | 7.0 (1–14) | 5.1 (0−30) | |
| Symptoms | |||
| Shortness of breath | 26 (78.8) | 60 (72.3) | 0.6389 |
| Cough | 30 (90.9) | 68 (81.9) | 0.2707 |
| Fever | 19 (57.6) | 51 (61.5) | 0.8337 |
| Chest Pain | 8 (24.2) | 25 (30.1) | 0.6500 |
| Diarrhea | 6 (18.1) | 16 (19.2) | 1.0000 |
| Vomiting | 4 (12.1) | 14 (16.9) | 0.7767 |
| Co-morbidities | |||
| Smoking | 2 (6.06) | 20 (24.1) | |
| Diabetes mellitus | 12 (36.4) | 24 (28.9) | 0.5061 |
| Hyperlipidemia | 9 (27.3) | 26 (31.3) | 0.6700 |
| Hypertension | 14 (42.4) | 44 (53.0) | 0.4107 |
| Heart Failure | 3 (9.0) | 6 (7.2) | 0.7124 |
| Ischemic Heart Disease | 1 (3.0) | 5 (6.0) | 0.6730 |
| Cancer | 3 (9.0) | 6 (7.2) | 0.7124 |
| COPD | 4 (12.1) | 13 (15.7) | 0.7751 |
| Asthma | 3 (9.0) | 14 (16.9) | 0.3885 |
| HIV/AIDS | 0 (0.0) | 2 (2.4) | 1.000 |
| Taking Immunomodulators | 0 (0.0) | 4 (4.8) | 0.5765 |
| Taking Chemotherapy | 0 (0.0) | 1 (1.2) | 1.000 |
| Taking Chronic Steroids | 0 (0.0) | 2 (2.4) | 1.000 |
| Obesity (BMI >30) | 14 (42.4) | 36 (43.4) | 1.000 |
P-values that are significant are bolded.